Dr. Aaron Pawlyk
|
DIVISION DIABETES, ENDOCRINOLOGY, & METABOLIC DISEASES
NIDDK, National Institutes of Health
Building 2DEM, Room 788B
6707 Democracy Blvd.
Bethesda, MD 20892
Tel: 301-451-7299
Email: pawlykac@mail.nih.gov
|
|
Current Position:
Program Director, Pharmacogenomics and Drug Discovery
Concurrent Positions:
Adjunct Assistant Professor, Department of Pharmacology and Physiology, Drexel University of College of Medicine
Current Portfolio/Responsibilities:
Program Director, Drug Discovery in Diabetes, Endocrinology and Metabolic Diseases
Program Director, Pharmacogenomics and Personalized Medicine in the Treatment of Diabetes
Science Officer, Molecular Libraries Screening Centers
Previous Training and Experience:
Ph.D., Texas A&M University (2001)
Post-doctoral Fellow, Center for Neurodegenerative Disease Research, University of Pennsylvania (2001 – 2003)
Post-doctoral Fellow, Center for Sleep and Respiratory Neurobiology, University of Pennsylvania (2003 – 2005)
Senior Research Scientist, Women’s Health Discovery Research, Wyeth Pharmaceuticals (2005 – 2008)
Senior Scientist, Discovery Research, Redpoint Bio Corporation (2008 – 2009)
Director of Pharmacology, ALS Biopharma (2009 – 2011)
Adjunct Professor of Pharmacology, Pennsylvania Drug Discovery Institute (2010 – 2011)
Committees/ Working Groups:
NIDDK Type 2 Diabetes Working Group
NIDDK Obesity Working Group
NIDDK Clinical Studies Working Group
Page last updated: March 29, 2011
